Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Get all the Latest News, Pictures, Videos and Special Report about Jyoti MaheshwariHitachi Payment Services Pvt. Ltd. by HT Auto.

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

If automobiles catch your fancy and you are captivated by all things on wheels, you have come to the right place. You have ...

Molson Coors Beverage Company TAP has posted fourth-quarter 2024 results, wherein the top and bottom lines beat the Zacks ...

Independent watch Maison H. Moser & Cie. has opened its first U.S. boutique at The Villa Menlo Park in Silicon Valley. This ...

Former Finance Minister Ken Ofori-Atta left Ghana in early January 2025 despite being summoned by the Special Prosecutor. Declared a fugitive, his failure to return raises serious legal and political ...